Catalonia.health, the organisation that represents companies in the biomedicine and health sector in Catalonia and of which Medichem is a member, has formalized the renewal of its Board of Directors and appointed Eva García Ramos as the new president of the organization at the General Assembly held in L’Hospitalet de Llobregat.
García Ramos, a Telecommunications Engineer with a General Management Program (PDG) from IESE, is CEO and co-founder of WIVI VISION, a pioneering company in digital health solutions with over 30,000 patients and more than 110 installations in Spain, currently in sales and expansion phases in the United States and Portugal. Under her leadership, WIVI VISION was recognized by Forbes in 2025 as one of the companies changing the world, and has accumulated over 70 national and international innovation awards, including the Donatic Award 2024 and various accolades from EIT Health and IBM.
“My career has shown me that innovation in digital health has a real impact on people’s lives. From Catalonia.health, we will work to strengthen the competitiveness of companies in the sector and to consolidate Catalonia as the leading health hub in southern Europe,” states Eva García Ramos, President of Catalonia.health.
Catalonia.health Board of Directors, renewed
García Ramos will lead a renewed Board of Directors composed of representatives from strategic sectors of the ecosystem: from biopharmaceutical product development and medical technologies to digital health and scientific-technical services. The members of the new executive team are: Jordi Martorell (Aortyx) as First Vice President; the outgoing president, Mariona Serra (GoodGut by Hipra) as Second Vice President; Pau Turón (Grup B. Braun) as Third Vice President and Treasurer; Marta Parente (GP Pharm) as Fourth Vice President; Elisabeth Stampa (Medichem) as Secretary and First Board Member; and Gabriel Capellá (IDIBELL), Jaume Vallet (COMSER), Laura Pellisé (AMGEN), Joël Jean-Mairet (YSIOS Capital), and Jordi Barretina (IGTP), as Second, Third, Fourth, Fifth, and Sixth Board Members respectively.
A visible, useful, and reliable association
The strategic lines of the new mandate are articulated around three commitments. To strengthen the visibility of the organization so that it has a presence where decisions affecting the sector are made; usefulness so that each member finds tangible returns in Catalonia.health in the form of opportunities, connections, and influence; and reliability to be recognized as a rigorous and constructive interlocutor. Additionally, the new president will work to promote alliances with various Catalan entities and institutions, and open new fronts of European and international collaboration in digital health, medical technologies, and advanced therapies.
